Bank Of Nova Scotia Tandem Diabetes Care Inc Transaction History

Bank Of Nova Scotia

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$53.22 - $123.09 $3.49 Million - $8.06 Million	-65,497 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$101.89 - $150.09 $6.67 Million - $9.83 Million	65,497 New	65,497 $7.62 Million
Q4 2021 Feb 11, 2022	SELL	$118.18 - $153.21 $1.13 Million - $1.46 Million	-9,543 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$93.51 - $129.4 $15 Million - $20.8 Million	-160,457 Reduced 94.39%	9,543 $1.14 Million
Q2 2021 Aug 12, 2021	BUY	$77.0 - $100.19 $13.1 Million - $17 Million	170,000 New	170,000 $16.6 Million

312

73.1M

3.25M

250K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.59B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.